Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Total Non-Current Liabilities (2011)

Updated

Mosaic ImmunoEngineering's Total Non-Current Liabilities came in at $575,577 for Q4 2011.

Analysis

Mosaic ImmunoEngineering (CPMV) Total Non-Current Liabilities (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Mosaic ImmunoEngineering 434,528.21 434,528.21 - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2011 575,577.00
API Access

Mosaic ImmunoEngineering Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CPMV&period=max&api_key=YOUR_API_KEY